Skip to content

Ezetimibe Deprotected Impurity

Ezetimibe Deprotected Impurity

Product Description
CAT No.
ALN-E026058
CAS No.
1185883-40-2
Mol. F.
C33H30F2N2O5
Mol. Wt.
572.6
Stock
Please Inquire
RFQ
Chemical Name : (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-hydroxyphenyl)methyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
Smiles : O=C(N1[C@@H](C2=CC=CC=C2)COC1=O)[C@H](CC[C@@H](C3=CC=C(F)C=C3)O)[C@@H](C4=CC=C(O)C=C4)NC5=CC=C(F)C=C5
Inchi : InChI=1S/C26H24FNO4/c1-31-24(29)16-15-23-25(28(26(23)30)21-11-9-20(27)10-12-21)19-7-13-22(14-8-19)32-17-18-5-3-2-4-6-18/h2-14,23,25H,15-17H2,1H3/t23-,25+/m1/s1

Related substances by HPLC method for the detection and evaluation of impurities in ezetimibe drug material

By Rapeti, Durgababu; Reddy, Gudibanda Chandra Sekhar; Narayanarao, Kapavarapu Maruthi Venkata; Shyamala, Pulipaka; Krishna, Rallabhandi MuralinFrom International Journal of Pharmaceutical Sciences and Research (2021), 12(1), 217-225

Stability-indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe from pharmaceuticals and biological samples

By Kurbanoglu, Sevinc; Esim, Ozgur; Ozkan, Cansel Kose; Savaser, Ayhan; Ozkan, Yalcin; Uslu, Bengi; Ozkan, Sibel A. – From Journal of the Turkish Chemical Society, Section A: Chemistry (2020), 7(3), 865-874

Stability-indicating analytical method development using quality by design approach for simultaneous estimation of ezetimibe and glimepiride

By Shah, U.; Shah, Kunti; Patel, Rupal – From Indian Journal of Pharmaceutical Sciences (2019), 81(2), 273-281

Request For Quotation

Related Products